Vyome Holdings (HIND) Other Operating Expenses (2020 - 2026)
Vyome Holdings (HIND) posted quarterly Other Operating Expenses of $2605.0 for Q1 2026, up 100.66% year-over-year from $1298.2 in Q1 2025, and down 3.09% quarter-over-quarter from $2688.0 in Q4 2025.
Vyome Holdings (HIND) Other Operating Expenses (2020 - 2026) Analysis & Trends
Vyome Holdings' Other Operating Expenses history runs 7 years deep, the most recent figure standing at $2605.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 100.66% year-over-year to $2605.0; the TTM figure through Mar 2026 stood at $8.2 million (up 75733.48% YoY), while the FY2025 annual figure was $7.7 million, up 866.65% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $2605.0, down from $2688.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $7.7 million in Q3 2025, with the low at -$396477.0 in Q1 2025.
- The 5-year median for Other Operating Expenses is $4427.0 (2024), against an average of $1.1 million.
- Peak annual rise in Other Operating Expenses reached 174021.05% in 2025, while the deepest fall reached 138.91% in 2025.
- Vyome Holdings' Other Operating Expenses stood at -$146000.0 in 2022, then jumped by 122.6% to $33000.0 in 2023, then plunged by 88.29% to $3864.0 in 2024, then tumbled by 30.43% to $2688.0 in 2025, then declined by 3.09% to $2605.0 in 2026.
- Business Quant data shows HIND's Other Operating Expenses at $2605.0 in Q1 2026, $2688.0 in Q4 2025, and $7.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,610.00 |
| Mar 31, 2026 | 2,605.00 |
| Dec 31, 2025 | 2,688.00 |
| Sep 30, 2025 | 7.71 Mn |
| Jun 30, 2025 | 487,000.00 |
| Mar 31, 2025 | -396,477.00 |
| Dec 31, 2024 | 3,864.00 |
| Sep 30, 2024 | 4,427.00 |
| Jun 30, 2024 | 399,000.00 |
| Mar 31, 2024 | 1.02 Mn |
| Jun 30, 2023 | 33,000.00 |
| Mar 31, 2023 | 4.22 Mn |
| Dec 31, 2022 | -146,000.00 |
| Sep 30, 2022 | -1,000.00 |
| Jun 30, 2022 | -381,000.00 |
| Mar 31, 2022 | 3.89 Mn |
| Dec 31, 2021 | 36.07 Mn |
| Sep 30, 2021 | 11.88 Mn |
| Jun 30, 2021 | 1.44 Mn |
| Mar 31, 2021 | 2.72 Mn |